| GWPAX | MNHCX | GWPAX / MNHCX | |
| Total Expense Ratio | 0.71 | 1.83 | 39% |
| Annual Report Gross Expense Ratio | 0.71 | 1.83 | 39% |
| Fund Existence | 14 years | 17 years | - |
| Gain YTD | 11.433 | 7.239 | 158% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 2000 | 13% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.4B | 401M | 6,833% |
| Annual Yield % from dividends | 0.34 | 0.00 | - |
| Returns for 1 year | 13.96 | 2.59 | 539% |
| Returns for 3 years | 59.95 | 21.60 | 278% |
| Returns for 5 years | 25.09 | -15.03 | -167% |
| Returns for 10 years | 110.74 | -5.21 | -2,124% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VTSMX | 184.10 | 0.90 | +0.49% |
| Vanguard MStar Total Stk Mkt Idx Invest | |||
| ACIPX | 17.30 | 0.07 | +0.41% |
| American Century Mid Cap Value G | |||
| NAPIX | 84.40 | N/A | N/A |
| Voya Multi-Manager International Sm Cp I | |||
| FPHAX | 35.95 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| FEUCX | 22.05 | N/A | N/A |
| Fidelity Advisor Glbl Capital Apprec C | |||